MITRE Licenses Glycomics Technology to Quickpath Technologies.MCLEAN, Va. -- The MITRE Corporation (body) MITRE Corporation - A US federally funded R&D center, spun off in 1958 from the MIT Lincoln Laboratory (also an FFRDC). MITRE is a non-profit corporation chartered to do R&D in the public interest. announced today that it has licensed to Quickpath Technologies, Inc. (Quickpath Bioscience) of Columbia, Maryland Columbia is a census-designated place and planned community in Howard County, Maryland, United States. It is a suburb of Baltimore, and, to a lesser degree, Washington, DC. It began with the idea that a city could enhance its residents' quality of life. its platform of technologies in the field of glycomics. The platform is derived from research conducted under the MITRE Technology Program. The technologies hold great promise in a broad range of bioscience and medical fields, with near-term application in the area of pathogen Pathogen Any agent capable of causing disease. The term pathogen is usually restricted to living agents, which include viruses, rickettsia, bacteria, fungi, yeasts, protozoa, helminths, and certain insect larval stages. capture. Quickpath Bioscience is targeting roll-out of its first commercial products in late 2007 or early 2008. This license agreement is an example of how MITRE's Technology Transfer Program can put technologies into the hands of commercial companies that can make them available to MITRE's sponsors and the public as supported, affordable products. In this case, MITRE's Technology Transfer Office is working with a technology start-up company start-up company A new business. . "The MITRE Technology Transfer Office has been actively seeking opportunities to license our technologies to startup companies. Licensing to technology start-up companies can be a very effective commercialization model, resulting in promising technologies being made available to the public. We are pleased to be working with the team at Quickpath" stated Gerard Eldering, director of MITRE's Technology Transfer Office. "The MITRE technology platform in the emerging field of glycomics has such broad potential, it's an exciting challenge," stated Quickpath's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Richard Spedden. "As with any emerging technology, we have some development work to do, but I am confident that we have a solid technology, talented staff and excellent partners for transforming it from science into a product with a compelling value proposition. Working with The MITRE Corporation on the technology transfer has been a pleasure." The MITRE Corporation is a not-for-profit organization chartered to work in the public interest. MITRE manages three Federally Funded Research and Development Centers Federally Funded Research and Development Centers (FFRDCs) conduct research for the United States Government. They are administered in accordance with U.S Code of Federal Regulations, Title 48, Part 35, Section 35.017 by universities and corporations. (FFRDCs) and also has its own independent research and development program that explores new technologies and new uses of technologies to solve sponsors' problems in the near-term and in the future. MITRE has over 5,900 scientists, engineers and support specialists. http://www.mitre.org Quickpath Technologies, Inc. (Quickpath Bioscience) is a start-up company with headquarters in Howard County, Maryland Howard County is a county located in the central part of the U.S. state of Maryland, between Baltimore and Washington, D.C.. It is considered part of the Baltimore-Washington Metropolitan Area. . http://www.quickpath.us |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion